Applications including "Draft for US Pharmacopeia"
-
LC254 - Analysis of Loperamide hydrochloride (Under the Condition of draft for USP PF52(4), Loperamide hydrochloride, Assay)(Under the Condition of draft for USP PF52(4), Loperamide hydrochloride Tablets, Assay) -
LC InertSearch Inertsil Hybrid-C18 -
LC253 - Analysis of Loperamide hydrochloride (Under the Condition of draft for USP PF52(4), Loperamide hydrochloride Capsules, Assay) -
LC InertSearch Inertsil Hybrid-C18 -
LC250 - Analysis of Apremilast (Under the Condition of draft for USP PF52(5), Apremilast, Assay) -
LC InertSearch InertSustain C8 -
LC249 - Analysis of Eslicarbazepine acetate (Under the Condition of draft for USP PF52(4), Eslicarbazepine Acetate Tablets, ORGANIC IMPURITIES) -
LC InertSearch InertSustain C8 -
LC248 - Analysis of Eslicarbazepine acetate (Under the Condition of draft for USP PF52(4), Eslicarbazepine Acetate Tablets, Assay) -
LC InertSearch InertSustain C8 -
GA404 - Analysis of Busulfan (Under the Condition of the draft for USP PF52(2), Busulfan, ORGANIC IMPURITIES) -
GC InertSearch InertCap 5 -
GA403 - Analysis of Busulfan (Under the Condition of the draft for USP PF52(2), Busulfan, ASSAY) -
GC InertSearch InertCap 5 -
LC015 - Analysis of Itraconazole (Under the draft for USP, Itraconazole Oral Solution, ASSAY) -
LC InertSearch InertSustain C18 -
GA387 - Analysis of Ethanol and Acetonitrile (Under the Condition for the Draft for USP, Tavaborole Topical Solution, Content of Alcohol) -
GC InertSearch InertCap FFAP

















